Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Early Oxybutynin Treatment for Boys with Posterior Urethral Valves

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Improving Bone Health in Children with Cystic Fibrosis Using Cholecalciferol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

    Recruiting

    2 1 1
    Investigated Drugs:
    Austria Belgium France Italy Spain
  • Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

    Recruiting

    3 1
    Belgium France Germany Ireland Italy The Netherlands +2
  • Study on the Safety of Inhaled Teicoplanin for Treating Staphylococcus aureus Infections in Cystic Fibrosis Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy The Netherlands
  • Study of Axitinib and Etoposide for Children and Young Adults with Refractory or Relapsing Medulloblastoma and Ependymoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    France
  • Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

    Recruiting

    3 1
    Investigated Diseases:
    Belgium Bulgaria Czechia Denmark France Germany +8
  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark Germany Italy Spain
  • Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Austria Belgium Denmark Finland France Germany +5